A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?
Background. Since neoadjuvant treatment in esophageal cancer began to become popular, a complete pathological response at the primary tumour site has been commonly reported. An issue of conflict is whether complete response in the esophageal lumen means that the esophagus is completely tumour-free....
Saved in:
Main Authors: | Sebahattin Celik (Author), Remzi Erten (Author), Abdulsamed Batur (Author), Burak Suvak (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of gastrostomy in the staged operation of esophageal atresia
by: Hosseini Seyed, et al.
Published: (2008) -
Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy
by: Ali Kermani, et al.
Published: (2020) -
Prognostic role of lymph node regression in patients with esophageal cancer undergoing neoadjuvant therapy
by: Pingrun Chen, et al.
Published: (2024) -
Successful staged management of long gap esophageal atresia
by: N.F. Tepeneu, et al.
Published: (2022) -
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
by: Hirsch Matani, et al.
Published: (2022)